ulipristal acetate has been researched along with Blood Loss, Surgical in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bongers, MY; de Milliano, I; Hehenkamp, WJK; Huirne, JAF; Radder, C; Thurkow, AL; van de Lande, J; van de Ven, PM; van Vliet, H | 1 |
| Alessandri, F; Ferrero, S; Leone Roberti Maggiore, U; Vellone, VG; Venturini, PL | 1 |
1 trial(s) available for ulipristal acetate and Blood Loss, Surgical
| Article | Year |
|---|---|
Ulipristal acetate vs gonadotropin-releasing hormone agonists prior to laparoscopic myomectomy (MYOMEX trial): Short-term results of a double-blind randomized controlled trial.
Topics: Adult; Blood Loss, Surgical; Contraceptive Agents, Hormonal; Double-Blind Method; Female; Gonadotropin-Releasing Hormone; Humans; Laparoscopy; Leiomyoma; Netherlands; Norpregnadienes; Operative Time; Sutures; Uterine Myomectomy; Uterine Neoplasms | 2020 |
1 other study(ies) available for ulipristal acetate and Blood Loss, Surgical
| Article | Year |
|---|---|
Three-month treatment with ulipristal acetate prior to laparoscopic myomectomy of large uterine myomas: a retrospective study.
Topics: Adult; Blood Loss, Surgical; Databases, Factual; Female; Humans; Laparoscopy; Leiomyomatosis; Norpregnadienes; Operative Time; Retrospective Studies; Treatment Outcome; Uterine Myomectomy; Uterine Neoplasms | 2016 |